Search

everythinglearnresearchcommunity

for

Search:↓

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

Stem cell therapy shows promise for treating hair loss in androgenetic alopecia.

BTA safely and effectively treats hair loss, and works better with FNS.

The document concludes that understanding the genes and pathways involved in hair growth is crucial for developing treatments for hair diseases.

Combining platelet-rich plasma with other treatments may improve hair growth in people with hair loss, but more research is needed.

The document concludes that various clinical methods are used to assess ageing skin and the effectiveness of anti-ageing products.

Different ethnic groups have unique hair growth patterns, with African hair growing slower and less dense, Asian hair growing fast but sparse, and Caucasian hair being densest; men are more likely to experience hair loss than women.

The model predicts hair breakage based on key hair properties and helps product developers.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

Thyroid function may influence hair loss after COVID-19.

More research is needed to understand hair and scalp disorders in people with skin of color.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

SVF injections improve hair growth and reduce hair loss in people with androgenic alopecia.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Low dose cyclical nutrition therapy can consistently and safely improve hair growth and density without needing anti-androgens.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Female pattern hair loss greatly affects quality of life, especially in younger patients, those with the condition for a long time, and those with mental health issues. A more comprehensive treatment approach is suggested.

Laser treatment for hair loss works equally well on different skin types, but more research is needed for very dark skin.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

Pili torti is a rare condition where hair is twisted and breaks easily, often linked to genetic disorders or other health issues.

Minoxidil and finasteride can slow hair loss and stimulate regrowth, but won't restore all lost hair or reverse complete baldness.

About 21.3% of young, healthy Chinese men experience hair loss. Hairlines are mostly linear or have a central protrusion. Hair is densest on the top and back of the head, and hair follicles usually have 1 or 2 hairs. This information can help in designing hair restoration procedures.

Hair loss and aging are caused by the breakdown of a key protein in hair stem cells.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Platelet-rich plasma is a promising and safe treatment for increasing hair density and thickness in women with chronic telogen effluvium.

10% minoxidil solution better promotes hair growth and reduces hair loss without significant side effects.